TAKEDA-Farmaceuticos Portugal, Lda secures contract for Antineoplastic and immunomodulating agents - 2023/0491 - LANADELUMAB [300 MG/2 ML SOL INJ SERINGA]

Portugal, Nov. 27 -- Portugal based TAKEDA-Farmaceuticos Portugal, Lda has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for Antineoplastic and immunomodulating agents - 2023/0491 - LANADELUMAB [300 MG/2 ML SOL INJ SERINGA]. The value of the contract is worth 29577500 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....